The ability of MicroScan rapid panels to detect high-level aminoglycoside-resistant enterococci was evaluated. By agar dilution, 46 of 139 isolates were susceptible to gentamicin (GNT) and streptomycin (STRP); the rest were highly resistant to one or both agents. Rapid panels detected 97.5% of STRP-and GNT-resistant isolates and had a specificity of 95.6%. Detection of resistance by conventional panels at 18 h was 64.6% for STRP and 90.2% for GNT.
Enterococci are significant human pathogens, and serious infections require therapy with penicillin or ampicillin plus streptomycin (STRP) or gentamicin (GNT). Isolates with high-level resistance to STRP (MIC > 2,000 ,ug/ml) were first described in 1970, and, in 1979, strains highly resistant to GNT were reported (1, 6) . Such strains are not killed by penicillin plus the respective aminoglycoside; therefore, to determine optimal therapy, clinically significant enterococci should be tested for high-level resistance to STRP and GNT.
The abilities of commercial systems to detect high-level aminoglycoside resistance vary. The sensitivity of the synergy screen (one well with 2,000 ,ug of GNT per ml and one with 2,000 ,ug of STRP per ml) in the reformulated conventional MicroScan panels (Baxter, West Sacramento, Calif.) at 18 to 24 h has ranged from 49 to 98% for STRP and from 42 to 100% for GNT (2, 4, 8, 9) . Recently, Baxter developed MicroScan panels that provide susceptibility test results in 3.5 to 15 h. These panels, which also have synergy screen wells with 2,000 ,ug of GNT or STRP per ml, must be incubated in and read with the WalkAway system. Antimicrobial agents are diluted in water with fluorogenic compounds, and the MICs are determined by comparing the increase in fluorescence in the antimicrobial agent dilutions with that in growth control wells.
The purpose of this study was to evaluate the reliability of MicroScan rapid panels for detection of high-level aminoglycoside-resistant enterococci. Synergy screen results provided by rapid and reformulated conventional MicroScan panels were compared with the reference agar dilution (agar screen) test.
Organisms. A total of 139 enterococci recovered from clinical specimens between February and September 1992 were tested. Quality control organisms recommended by the manufacturer were tested regularly. Enterococcus faecalis ATCC 29212 and an E. faecalis strain known to be highly resistant to GNT and STRP were susceptible and resistant controls, respectively, for the agar screen.
MicroScan panels. Reformulated conventional (Pos Combo Type 6) and rapid (Pos Combo Type 1) panels were inoculated, incubated, and read according to the manufac-* Corresponding author. were correctly read as resistant, and one of the two GNTsusceptible strains was correctly read as susceptible.
The MicroScan rapid synergy screen results in our study are similar to those of Nolte et al. (3) , who tested 37 E. faecalis strains with high-level resistance to one or both aminoglycosides. In their evaluation, rapid panels detected 100% of isolates resistant to STRP, GNT, or both and gave one false-resistant GNT result (specificity, 96%). Our data regarding reformulated conventional panels are most similar to those of Louie et al. (2) and Sahm et al. (4) , who reported lower sensitivities at 18 h (80 and 59%, respectively, for GNT; 77 and 65%, respectively, for STRP) than at 48 h (97 and 89%, respectively, for GNT; 84 and 88%, respectively, for STRP). In other studies, sensitivities at 18 h have been higher (95 to 100% for GNT and 85 to 98% for STRP) (3, 7, 8) . The reasons for this discrepancy are not apparent.
In summary, we found that MicroScan rapid Pos Combo Type 1 panels reliably detect high-level aminoglycosideresistant enterococci in 3.5 to 15 h and most in 4.5 to 5.5 h. Their major drawback is the requirement for the WalkAway system. MicroScan conventional Pos Combo Type 6 panels also are suitable for the detection of resistance but only after incubation for 48 h.
